rs2301703

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000352.6(ABCC8):​c.579+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.395 in 1,592,216 control chromosomes in the GnomAD database, including 129,616 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.47 ( 18440 hom., cov: 32)
Exomes 𝑓: 0.39 ( 111176 hom. )

Consequence

ABCC8
NM_000352.6 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:14

Conservation

PhyloP100: 0.634

Publications

13 publications found
Variant links:
Genes affected
ABCC8 (HGNC:59): (ATP binding cassette subfamily C member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
ABCC8 Gene-Disease associations (from GenCC):
  • hyperinsulinemic hypoglycemia, familial, 1
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Illumina, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • diabetes mellitus, permanent neonatal 3
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • familial hyperinsulinism
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • diabetes mellitus
    Inheritance: SD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • monogenic diabetes
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hypoglycemia, leucine-induced
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • transient neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • permanent neonatal diabetes mellitus
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • diabetes mellitus, transient neonatal, 2
    Inheritance: Unknown, AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • pulmonary arterial hypertension
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant hyperinsulinism due to SUR1 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • DEND syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive hyperinsulinism due to SUR1 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • type 2 diabetes mellitus
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-17463424-G-A is Benign according to our data. Variant chr11-17463424-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 157707.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.694 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC8NM_000352.6 linkc.579+14C>T intron_variant Intron 4 of 38 ENST00000389817.8 NP_000343.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC8ENST00000389817.8 linkc.579+14C>T intron_variant Intron 4 of 38 1 NM_000352.6 ENSP00000374467.4

Frequencies

GnomAD3 genomes
AF:
0.470
AC:
71455
AN:
151990
Hom.:
18395
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.701
Gnomad AMI
AF:
0.391
Gnomad AMR
AF:
0.429
Gnomad ASJ
AF:
0.477
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.295
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.538
Gnomad NFE
AF:
0.385
Gnomad OTH
AF:
0.475
GnomAD2 exomes
AF:
0.389
AC:
85736
AN:
220200
AF XY:
0.379
show subpopulations
Gnomad AFR exome
AF:
0.708
Gnomad AMR exome
AF:
0.405
Gnomad ASJ exome
AF:
0.475
Gnomad EAS exome
AF:
0.382
Gnomad FIN exome
AF:
0.291
Gnomad NFE exome
AF:
0.381
Gnomad OTH exome
AF:
0.400
GnomAD4 exome
AF:
0.387
AC:
557883
AN:
1440108
Hom.:
111176
Cov.:
31
AF XY:
0.384
AC XY:
274462
AN XY:
714258
show subpopulations
African (AFR)
AF:
0.715
AC:
23722
AN:
33162
American (AMR)
AF:
0.409
AC:
17065
AN:
41764
Ashkenazi Jewish (ASJ)
AF:
0.470
AC:
12037
AN:
25634
East Asian (EAS)
AF:
0.389
AC:
15168
AN:
39040
South Asian (SAS)
AF:
0.291
AC:
24104
AN:
82804
European-Finnish (FIN)
AF:
0.299
AC:
15545
AN:
51918
Middle Eastern (MID)
AF:
0.466
AC:
2647
AN:
5676
European-Non Finnish (NFE)
AF:
0.384
AC:
422867
AN:
1100450
Other (OTH)
AF:
0.414
AC:
24728
AN:
59660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
16721
33443
50164
66886
83607
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13358
26716
40074
53432
66790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.470
AC:
71544
AN:
152108
Hom.:
18440
Cov.:
32
AF XY:
0.464
AC XY:
34481
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.701
AC:
29098
AN:
41500
American (AMR)
AF:
0.429
AC:
6560
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
1656
AN:
3470
East Asian (EAS)
AF:
0.400
AC:
2059
AN:
5146
South Asian (SAS)
AF:
0.296
AC:
1425
AN:
4822
European-Finnish (FIN)
AF:
0.291
AC:
3085
AN:
10600
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.385
AC:
26157
AN:
67958
Other (OTH)
AF:
0.471
AC:
992
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1819
3639
5458
7278
9097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.429
Hom.:
6918
Bravo
AF:
0.493
Asia WGS
AF:
0.356
AC:
1240
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:14
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Diabetes mellitus, transient neonatal, 2 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hyperinsulinemic hypoglycemia, familial, 1 Benign:2
Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Type 2 diabetes mellitus Uncertain:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Mutations in ABCC8 gene are generally associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may respond to sulfonylureas. Although, rs2301703 prevalence in Neonatal Diabetes mellitus is seen, its association with T2DM is yet to be ascertained. -

Leucine-induced hypoglycemia Benign:1
Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Diabetes mellitus, permanent neonatal 3 Benign:1
Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Permanent neonatal diabetes mellitus Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
7.3
DANN
Benign
0.71
PhyloP100
0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2301703; hg19: chr11-17484971; COSMIC: COSV56856529; COSMIC: COSV56856529; API